Abnormalwbcnfrspecfc
A specialized laboratory test that uses flow cytometry to detect and analyze abnormal white blood cells in your blood sample.
{"This test identifies abnormal white blood cells using advanced laser technology","It helps diagnose blood disorders like leukemia and lymphoma","A blood sample is sent to a laboratory for analysis","Results help doctors determine the type and severity of blood cell abnormalities","The test is more detailed than a standard blood count"}
Key facts at a glance
- LOINC
- 67128-9
- Short code
- ABNLEUKFC
- Synonyms
- Abnormal WBC NFr Spec FC
- Category
- chemistry
- Sample
- serum
- Container
- Lavender top (EDTA) tube or sterile collection container for body fluids
- Units
- N/A
- Ref low
- 4.5
- Ref high
- 11
- Critical range
- 2 N/A – 30 N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 18 years
- Method
- flow-cytometry
- CPT
- 86355
- SNOMED
- 44027006
- Specimen volume
- 2-3 mL whole blood or 1-2 mL body fluid
- Stability
- Whole blood: 24-48 hours at room temperature; Body fluids: Process within 2-4 hours of collection
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
What is this test?
Flow cytometry is a sophisticated laboratory technique that analyzes cells as they pass through a laser beam. This test specifically looks at white blood cells (leukocytes) in your blood to detect any abnormalities in their size, shape, and surface markers. It can identify specific types of white blood cells and detect cancerous or precancerous changes.
How is the test performed?
A healthcare provider will draw a blood sample from your arm. The sample is then sent to a laboratory where it is treated with fluorescent dyes that bind to specific proteins on the surface of white blood cells. The cells are then passed through a flow cytometer, which uses lasers to measure the fluorescence and scatter of light, providing detailed information about each cell's characteristics.
Why might I need this test?
Your doctor may order this test if you have symptoms suggesting a blood disorder, such as unexplained fatigue, frequent infections, easy bruising or bleeding, or abnormal results from a complete blood count (CBC). It is commonly used to diagnose and monitor conditions like leukemia, lymphoma, and other disorders affecting white blood cells.
What should I expect?
The test is similar to a regular blood draw. You may feel a brief sting when the needle is inserted. There is minimal risk involved, though you might experience slight bruising or bleeding at the puncture site. Results are typically available within a few days to a week, depending on the laboratory.
Reference range
Adult: 4.5-11.0 x 10^9/LN/A
No special preparation required. Collect specimen according to standard venipuncture procedures. Inform laboratory of any recent chemotherapy, bone marrow transplant, or immunosuppressive therapy.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Frequently asked questions
Do I need to fast before this test?
Is this test painful?
How long does it take to get results?
What do abnormal results mean?
Are there any risks from this test?
Sources
- 1
- 2
- 3Mayo Clinic - LeukemiaSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy